A significant alert has been sounded by the World Health Organization concerning the ongoing Ebola outbreak in the Democratic Republic of Congo. Just two months after the epidemic was officially declared, the latest figures released on July 15 reveal a grim reality: over 2,000 confirmed cases and 796 tragic deaths. Yet, the organization warns that the actual number of people infected could be two to four times higher than these official statistics. This raises critical questions: what accounts for such a substantial disparity in numbers? Why is this particular Ebola epidemic proving exceptionally difficult to control and contain? And could the launch of a pioneering post-exposure prophylaxis clinical trial in Bunia this week mark a crucial turning point in the battle against the virus?
